PE Firms Deployed $40.4 Billion in CPG Deals
Investors are scaling activity in food and beverage, targeting high-growth supplement and hydration brands.
Updated on Oct. 7, 2026 in Consumer Goods
Live Poll
Do you trust private equity firms to manage the food and beverage brands you buy?
Private equity firms invested $40.4 billion across 447 food and beverage deals through the first nine months of 2026. This activity was headlined by a $14.4 billion investment surge in Q3 alone.
Why it matters
The sustained capital inflow into consumer goods signals that sponsors view niche health and wellness segments as recession-resilient. Operators in these categories should anticipate increased competition for mid-market assets as firms look to deploy dry powder.
Investment reached $40.4 billion across 447 food and beverage deals through Q3 2026. Europe dominated the Q3 activity with $8.6 billion in deals, representing 71.1% of global value for the quarter.
The players
Platinum Equity
A global private equity firm specializing in mergers and acquisitions, operations, and portfolio management.
L Catterton
A consumer-focused private equity firm backed by LVMH and Arnault family interests.
Procter & Gamble
A multinational consumer goods corporation managing a portfolio of health, hygiene, and personal care brands.
Nestlé
A global food and drink processing conglomerate with a significant footprint in hydration and consumer health.
The details
The sector has seen significant movement in high-margin verticals, including a $1.2 billion buyout of Vitabiotics and a $1 billion growth round for Luckin Coffee. Strategic realignments are also underway, such as Platinum Equity entering a joint venture involving Nestlé's waters business and L Catterton reaching a $3.8 billion agreement to sell Thorne Research to Procter & Gamble.
Timeline
2021 served as the reference point for North American deal counts.
Q2 2026 saw health and wellness exits account for 21.6% of the total.
Q3 2026 served as the reporting period for deal and exit data.
Q4 2026 is the expected window for the Thorne Research sale to close.
Market Landscape
This wave of capital deployment follows the precedent set by the historical trend of consumer health M&A consolidation. The current figures reflect an intensification of that trend as firms prioritize supplement and hydration assets.
Operators in the health and wellness space should monitor supplement deal multiples as these sectors remain high-priority for sponsors. Prepare for potential supply chain or distribution changes if your business is acquired by or partnered with a PE-backed entity.
The takeaway
The sustained liquidity in the CPG market indicates that specialized health and hydration brands remain top targets for institutional buyers. Monitor deal valuations in your specific sub-sector to benchmark your own company's position against current market sentiment.
What happens next
The $3.8 billion sale of Thorne Research to Procter & Gamble is expected to conclude in Q4 2026.
Further reading
For more on industry shifts, visit our section on Consumer Goods.
Source note: This article includes information reported by Pitchbook.
Live Poll
Do you trust private equity firms to manage the food and beverage brands you buy?
